查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608064

免疫检测分析仪市场：按产品和应用划分－2025年至2030年全球预测

Immunoassay Analyzers Market by Product (Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay), Application (Autoimmune Disease, Cardiology, Endocrinology) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年免疫检测分析仪市值为121.5亿美元，预计到2024年将达到127.2亿美元，复合年增长率为6.92%，到2030年将达到194.3亿美元。

生物标记物的准确检测和定量对于使用免疫检测分析仪进行生物医学研究和诊断测试至关重要。该市场包括按类型、应用和最终用户（例如医院、实验室和诊断中心）细分的自动分析仪和手动分析仪。这些分析仪对于个人化医疗中的疾病管理、治疗监测和诊断至关重要。慢性病的增加、人口老化和生物技术的进步是市场成长的主要驱动力。对个人化医疗的需求不断增长以及免疫检测技术的进步也将推动市场的发展。一个关键的商业机会是将人工智慧和机器学习整合到这些分析设备中，以提高其预测分析能力和开拓，并进入由消费者对更容易获得的医疗保健解决方案的需求驱动的快速增长的家庭测试市场。然而，市场面临先进免疫检测分析仪的高成本和复杂的法规环境等挑战，这些挑战正在减缓市场渗透和技术采用。此外，在发展中地区，对专业操作技能的需求可能是一个障碍。为了克服这些问题，注重成本效益、使用者友好的仪器和强大的分析技术的创新至关重要。公司应进一步开发低成本生物感测器和可携式免疫检测设备，以适应日益必要的就地检验。从研究的角度来看，探索整合奈米技术和微流体的下一代免疫测量平台有望提高灵敏度和准确性。此外，与生物技术公司的策略联盟和合作可实现快速技术整合和市场扩张。市场竞争激烈且不断发展，对创新的需求强劲，以满足医疗保健环境的多样化需求。因此，专注于技术突破和适应策略可以开拓重要的市场份额和业务成长。

主要市场统计
基准年[2023] 121.5亿美元
预测年份 [2024] 127.2亿美元
预测年份 [2030] 194.3亿美元
复合年增长率（%） 6.92%

市场动态：揭示快速发展的免疫检测分析仪市场的关键市场洞察

供需的动态交互作用正在改变免疫检测分析仪市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 癌症领域对免疫测量的高需求
    • 基于免疫测量的就地检验和快速检测日益普及
    • 要求进行药物和酒精测试的严格规定
  • 市场限制因素
    • 不利的赎回措施
    • 严格的核准规定
  • 市场机会
    • 持续开发用于诊断微生物感染疾病的免疫检测分析仪
    • 融合先进技术，改良产品
  • 市场问题
    • 免疫检测分析仪误读

波特五力：驾驭免疫检测分析仪市场的策略工具

波特的五力框架是了解免疫检测分析仪市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解免疫检测分析仪市场的外部影响

外部宏观环境因素在塑造免疫检测分析仪市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解免疫检测分析仪市场的竞争格局

对免疫检测分析仪市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：免疫检测分析仪市场供应商的绩效评估

FPNV定位矩阵是评估免疫检测分析仪市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划免疫检测分析仪市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，免疫检测分析仪市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肿瘤学中对免疫检测的使用有很高的需求
      • 增加就地检验和快速免疫检测检测的采用
      • 要求进行药物和酒精测试的严格规定
    • 抑制因素
      • 不利的退款政策
      • 严格的核准规定
    • 机会
      • 持续开发用于诊断微生物感染疾病的免疫检测分析仪
      • 融合先进技术，改良产品
    • 任务
      • 免疫检测分析仪读数不正确
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章免疫检测分析仪市场：副产品

  • 介绍
  • 化学冷光免疫检测
  • 耗材及配件
  • 酵素免疫分析法
  • 萤光分析仪
  • 免疫检测

第七章免疫检测分析仪市场：依应用分类

  • 介绍
  • 自体免疫疾病
  • 心臟病学
  • 内分泌学
  • 传染病检查
  • 肿瘤学
  • 治疗监测

第 8 章：美洲免疫检测分析仪市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太免疫检测分析仪市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲免疫检测分析仪市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Boditech Med Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Ortho-Clinical Diagnostics, Inc.
  • Quidel Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • WAK-Chemie Medical GmbH
Product Code: MRR-ED54C46E890E

The Immunoassay Analyzers Market was valued at USD 12.15 billion in 2023, expected to reach USD 12.72 billion in 2024, and is projected to grow at a CAGR of 6.92%, to USD 19.43 billion by 2030.

Immunoassay analyzers are crucial in biomedical research and diagnostic testing, offering precise detection and quantification of biological markers. The scope of this market includes automated and manual analyzers segmented by type, application, and end-user, such as hospitals, research labs, and diagnostic centers. These analyzers are pivotal for diagnostics in disease management, therapeutic drug monitoring, and personalized medicine. The growing prevalence of chronic diseases, an aging population, and advances in biotechnology are significant drivers for market growth. Increasing demand for personalized medicine and advancements in immunoassay technology also propel the market. Key opportunities emerge with the integration of AI and machine learning in these analyzers, enhancing predictive analytics capabilities and efficiency, as well as tapping into the burgeoning home testing market driven by consumer demands for more accessible healthcare solutions. However, the market faces challenges such as high costs of advanced immunoassay analyzers and complex regulatory environments, which can slow down market penetration and technology adoption. Additionally, the need for specialized operating skills can be a barrier in developing regions. To overcome these, innovations focusing on cost-effective, user-friendly devices, and robust analytical technologies are crucial. Companies should further explore developing low-cost biosensors and portable immunoassay devices suitable for point-of-care testing, which is increasingly becoming a necessity. From a research standpoint, exploring next-generation immunoassay platforms that integrate nanotechnology or microfluidics could enhance sensitivity and accuracy. Furthermore, strategic collaborations and partnerships with biotechnology firms can facilitate quicker technology integration and market expansion. The market is competitive, evolving, with robust demand for innovation to meet the growing needs of diverse healthcare settings. Therefore, focusing on technological breakthroughs and adaptive strategies can carve out significant market presence and business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 12.15 billion
Estimated Year [2024] USD 12.72 billion
Forecast Year [2030] USD 19.43 billion
CAGR (%) 6.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoassay Analyzers Market

The Immunoassay Analyzers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High demand for use of immunoassays in oncology
    • Rising penetration of immunoassay-based point-of-care testing and rapid testing
    • Stringent regulation mandating drug and alcohol testing
  • Market Restraints
    • Unfavorable reimbursement policies
    • Stringent regulation for approvals
  • Market Opportunities
    • Constant development of immunoassay analyzers to diagnose microorganism-based infections
    • Integration of advanced technologies and product improvements
  • Market Challenges
    • False readings in immunoassay analyzers

Porter's Five Forces: A Strategic Tool for Navigating the Immunoassay Analyzers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoassay Analyzers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoassay Analyzers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoassay Analyzers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoassay Analyzers Market

A detailed market share analysis in the Immunoassay Analyzers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoassay Analyzers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoassay Analyzers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoassay Analyzers Market

A strategic analysis of the Immunoassay Analyzers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoassay Analyzers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Boditech Med Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Merck KGaA, Ortho-Clinical Diagnostics, Inc., Quidel Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and WAK-Chemie Medical GmbH.

Market Segmentation & Coverage

This research report categorizes the Immunoassay Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay, Immunofluorescence Analyzers, and Radioimmunoassay.
  • Based on Application, market is studied across Autoimmune Disease, Cardiology, Endocrinology, Infectious Disease Testing, Oncology, and Therapeutic Drug Monitoring.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High demand for use of immunoassays in oncology
      • 5.1.1.2. Rising penetration of immunoassay-based point-of-care testing and rapid testing
      • 5.1.1.3. Stringent regulation mandating drug and alcohol testing
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement policies
      • 5.1.2.2. Stringent regulation for approvals
    • 5.1.3. Opportunities
      • 5.1.3.1. Constant development of immunoassay analyzers to diagnose microorganism-based infections
      • 5.1.3.2. Integration of advanced technologies and product improvements
    • 5.1.4. Challenges
      • 5.1.4.1. False readings in immunoassay analyzers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoassay Analyzers Market, by Product

  • 6.1. Introduction
  • 6.2. Chemiluminescence Immunoassay
  • 6.3. Consumables & Accessories
  • 6.4. Enzyme-linked Immunoassay
  • 6.5. Immunofluorescence Analyzers
  • 6.6. Radioimmunoassay

7. Immunoassay Analyzers Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Disease
  • 7.3. Cardiology
  • 7.4. Endocrinology
  • 7.5. Infectious Disease Testing
  • 7.6. Oncology
  • 7.7. Therapeutic Drug Monitoring

8. Americas Immunoassay Analyzers Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Immunoassay Analyzers Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Immunoassay Analyzers Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Beckman Coulter, Inc.
  • 3. Becton Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux SA
  • 6. Boditech Med Inc.
  • 7. DiaSorin S.p.A.
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Merck KGaA
  • 10. Ortho-Clinical Diagnostics, Inc.
  • 11. Quidel Corporation
  • 12. Siemens Healthineers AG
  • 13. Sysmex Corporation
  • 14. Thermo Fisher Scientific Inc.
  • 15. WAK-Chemie Medical GmbH

LIST OF FIGURES

  • FIGURE 1. IMMUNOASSAY ANALYZERS MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOASSAY ANALYZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOASSAY ANALYZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOASSAY ANALYZERS MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023